Metabolic syndrome at baseline was not predictive to new-onset cardiovascular diseases in patients with systemic lupus erythematosus: A prospective observational registry
Objective: It has been established that metabolic syndrome is prevalent in patients with systemic lupus erythematosus (SLE). The objective of this study was to investigate the effect of metabolic syndrome at baseline on new-onset cardiovascular disease (CVD) in patients with SLE. Methods: The demogr...
Main Authors: | Choe, J.-Y (Author), Kim, S.-K (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications Inc.
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas
by: Ole Petter Rekvig
Published: (2018-03-01) -
Anti-nucleosome antibodies in systemic lupus erythematosus patients: Relation to anti-double stranded deoxyribonucleic acid and disease activity
by: Mayada Ali Abdalla, et al.
Published: (2018-01-01) -
Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis
by: Daniele Faria Miguel, et al.
Published: (2020-02-01) -
Estudo longitudinal do anticorpo antilipoproteína lipase e sua relação com atividade de doença nos indivíduos com lúpus eritematoso sistêmico sem anticorpos anti-dsDNA Longitudinal fluctuation of anti-lipoprotein lipase antibody is related with disease activity in systemic lupus erythematosus patients without anti-dsDNA antibodies
by: Jozélio Freire de Carvalho, et al.
Published: (2009-02-01) -
CCR6+ Th cell distribution differentiates systemic lupus erythematosus patients based on anti-dsDNA antibody status
by: Wei Zhong, et al.
Published: (2018-02-01)